Status not kept up to date
SBRT/RT in Oligometastatic Stage IV NSCLC
NCT05647590 · University Hospital Ostrava · Updated 30 Jan 2024
- What is being tested
- Chemotherapy; Radiotherapy (RT) + Stereotactic Body Ratio Therapy (SBRT); Maintenance chemotherapy
- For
- Non Small Cell Lung Cancer
- Kind of study
- Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
- Who can join
- Ages 18 years to 85 years. About 10 people. The full rules are on the registry page.
- Where
- Czechia
- When
- Starts or started 1 Oct 2019, ends 31 Dec 2025. Registered 12 Dec 2022.
- Results
- None posted yet.
In the researchers' words
The core hypothesis to be tested is that the use of consolidative SBRT followed by maintenance chemotherapy in patients with less than or equal to 10 metastatic sites will improve progression-free survival (PFS) with acceptable toxicity compared to maintenance chemotherapy alone.
Sites
- University Hospital OstravaOstrava, Moravian-Silesian Region, Czechia